ashpublications.org › blood › Overview-of-Castleman-disease

Castleman disease (CD) describes a group of at least 4 disorders that share a spectrum of characteristic histopathological features but have a wide range of etiologies, presentations, treatments, and outcomes. …

ashpublications.org › ... › Treatment-of-Castleman-Disease

The QuestionWhat are your treatment approaches to Castleman disease with the advent of anti–interleukin-6 therapy?Our ResponseCastleman disease (CD) describes a group of heterogeneous lymphoproliferative disorders that share common histopathological lymph…

ashpublications.org › ... › 39506 › International-evidence-based-consensus-treatment

Successful treatment of a patient with multicentric Castleman’s disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody

onkopedia.com › de › morbus-castleman

Advani R, Warnke R, Rosenberg S: Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support. Ann Oncol 10:1207-1209, 1999.

pubmed.ncbi.nlm.nih.gov › 30181172

An international Working Group of 42 experts from 10 countries was convened by the Castleman Disease Collaborative Network to establish consensus guidelines for the management of iMCD based on published…

24. JAN.

mayoclinic.org › diseases-conditions ›

Treatment options for multicentric Castleman disease may include: Immunotherapy. The use of drugs such as siltuximab (Sylvant) or rituximab (Rituxan) can block the action of a protein... Chemotherapy. This type…

onlinelibrary.wiley.com › doi › bjh

Castleman disease remains a diagnostic and therapeutic challenge. It is now clear that UCD and the subtypes of MCD have different presentations and pursue different clinical courses, which should guide…

b-s-h.org.uk › guidelines › guidelines › guideline-the-management-of-castleman-disease

Date: 02 August 2021. Castleman disease (CD) describes a rare group of lymphoproliferative disorders with characteristic histopathological appearances. 1 Unicentric CD (UCD) presents with isolated lymphadenopathy, usually accompanied by mild…

pubmed.ncbi.nlm.nih.gov › 34340261

Adrenal Cortex Hormones / therapeutic use. Anti-Retroviral Agents / therapeutic use. Antibodies, Monoclonal / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biopsy. Castleman Disease / diagnosis. Castleman Disease…

ashpublications.org › ... › 107833 › How-I-treat-HIV-associated-multicentric-Castleman

Rituximab therapy for HIV-associated Castleman disease: long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood

my.clevelandclinic.org › health › diseases › 17920

Management and Treatment How is Castleman disease managed or treated? Treatment for Castleman disease varies according to the type. Unicentric Castleman disease (UCD) treatment. Surgery to remove the affected lymph…

emedicine.medscape.com › article › 2219018-treatment

For unicentric Castleman disease (UCD), surgical removal of the enlarged lymph node is considered the first-line treatment option and can be curative. Systemic manifestations and laboratory abnormalities, if present, tend…